Health News
Synageva BioPharma Corp. , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the Jefferies 2012 Global Health Care Conference being held in New York City.
21 minutes ago
Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the Goldman Sachs Global Healthcare Conference 2012 to be held June 5-7, 2012 at Terranea in Rancho Palos Verdes, CA. Mr. Adrian Adams, Chief Executive ...
23 minutes ago
Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
23 minutes ago
Isis Pharmaceuticals, Inc. , the leader in antisense therapeutics, today announced that management will present a company overview at the Goldman Sachs 33rd Annual Global Healthcare Conference on Tuesday, June 5, 2012 at 1:20 p.m. PT at the ...
23 minutes ago
Teleflex Incorporated announced today the Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter has received 510 clearance from the U.S. Food and Drug Administration .
24 minutes ago
Amedisys, Inc. , one of America's leading home health and hospice companies, today announced that William F. Borne, Chief Executive Officer and Ronald A. LaBorde, President and Chief Financial Officer will present at the Jefferies 2012 Global ...
24 minutes ago
Repligen Corporation today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present a corporate update at the Jefferies 2012 Global Healthcare Conference in New York. The Repligen presentation is scheduled for ...
24 minutes ago
Acorda Therapeutics, Inc. , makers of Ampyra , today announced the launch of Ampyra Dialogues, the first-ever online talk show where patients and medical experts talk about how walking problems affect people living with MS. The first edition of ...
24 minutes ago
HealthHelp announced today its major-level sponsorship of Institute 2012. America's Health Insurance Plans' annual conference for health insurance decision makers will take place June 20 through 22 at the Calvin L. Rampton Salt Palace Convention ...
24 minutes ago
Illumina, Inc. today announced that it will webcast the company's presentations at two upcoming investment conferences.
54 minutes ago
Foundation Medicine announced today the commercial launch of FoundationOne , the first pan-cancer, fully informative genomic profile designed to help oncologists expand their patients' treatment options. FoundationOne is optimized to fit current ...
54 minutes ago
AVEO Oncology today announced that the AVEO management team will host a conference call on Monday, June 4, 2012 at 7:30 a.m. to review the Phase 3 TIVO-1 data that will be presented at the 2012 Annual Meeting of the American Society of Clinical ...
54 minutes ago
Exelixis, Inc. today announced that it has completed the filing of its rolling New Drug Application with the U.S. Food and Drug Administration for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or ...
82 minutes ago
Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer . The primary endpoint for COMET-1 is overall survival in mCRPC patients who have had ...
82 minutes ago
Biocept, Inc., a CLIA-certified laboratory testing company focused on oncology diagnostics, specifically the detection and analysis of circulating tumor cells in cancer patients, announced that with collaborators from Columbia University Medical ...
83 minutes ago
1 - 15 of 140874 Stories
<<
<
Next 15 Health News
>
>>
Search News
